Biomedical Advanced Research and Development Authority (BARDA) will release a new Broad Agency Announcment (BAA) on 4 March, 2012 for Advanced Research and Development of CBRN Medical Countermeasures.
The purpose of the BAA is to solicit and fund proposals that focus on the following research areas in order to advance the knowledge and scientific understanding of selected candidates’ countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS):
- Vaccines Development
- Antitoxins and Therapeutics
- Antimicrobials and Antivirals
- Radiological and Nuclear Agent Countermeasures
- Chemical Agent Countermeasures
- Diagnostics
BARDA, under the Department of Health and Human Services, encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).
The solicitation number is BARDA-CBRN-BAA-12-100-SOL-00011 with details available here. It is anticipated that a pre-proposal conference will be held in late April, 2012 in the Washington D.C. area and possibly a opportuntity for organizations to participate by phone. Global Biodefense will publish further details as they become available.
